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Abstract 
Philenoptera violacea (klotzsch) Schrire and Xanthocercis zambesiaca (Baker) Dumaz-le-Grand methanolic 
extracts mutagenic and antimutagenic properties were determined by Ames test using Salmonella 
typhimurium strains TA98 and TA100 without S9.  The cytotoxic effects of the extracts were tested by 
Sulforhodamine B assay on the WI38 cell line. Radioprotective effect of Xanthocercis zambesiaca (Baker) 
Dumaz-le-Grand was determined using the clonogenic assay. Results revealed that both plants do not have 
mutagenic effects against all tester strains without the presence of metabolic activation and with no direct 
carcinogenic potential to human cells. Liquid chromatography-mass spectrometry analysis showed the 
presence of two unknown compounds from Philenoptera violacea (klotzsch) Schrire. Based on clonogenic cell 
survival, Xanthocercis zambesiaca (Baker) Dumaz-le-Grand can lead to over 50% reduction in cell death. We 
therefore conclude that both plant extracts can be considered safe as the absence of mutagenicity indicates 
lack of toxicity and this was also confirmed by the negative cytoxicity screening. 
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Introduction  
Numerous medicinal plants are traditionally used in 
the treatment of a variety of diseases by African 
population. Among the plants used for therapeutic 
purposes are Philenoptera violacea (klotzsch) 
Schrire and Xanthocercis zambesiaca (Baker) 
Dumaz-le-Grand species, which both belong to the 
Fabaceae family [1]. Philenoptera violacea (klotzsch) 
Schrire has traditionally been used to treat gastro-
intestinal problems, powdered root-bark for colds 
and snakebite treatment, earache treatment, root 
infusions as hookworm remedy and most part of 
the plant to treat diarrhoea [2-3]. Xanthocercis 
zambesiaca has been traditionally used to treat 
diabetes mellitus and tuberculosis [4] and literature 
did support its antihyperglycemic activity [4] and 
anti-tuberculosis activity [5]. Although plants used 
medicinally are widely assumed to be safe by its 
users, the issue of quality control may be 
addressed. These plant extracts should 
consequently be examined carefully for their safety 
perspective and caution to their use should be 
taken.  
Plant polyphenols are important components of 
human diet and a number of them are considered 
to possess chemopreventive and therapeutic 
properties against cancer [6]. A large number of 
plants containing antioxidant phytochemicals are 
reported to be radioprotective in various model 
systems [7]. Most plants with antioxidant properties 
have shown anticarcinogenic activities in several in 
vitro and in vivo assays [8-11]. They have also 
shown the capacity to modulate radiation-induced 
damage by means of various biological endpoints, 
by radiosensitizing tumor cells while radioprotecting 
non-cancerous cells [6]. This suggests that, besides 
the anticarcinogenic effect, another possible 
application of the antioxidant capacity of 
polyphenols from plants could be based on their 
radioprotective activity. Xanthocercis zambesiaca 
(Baker) Dumaz-le-Grand showed the ability to 
scavenge free radicals thus its radioprotective effect 
was evaluated on radiation-induced human 
prostate cancer cell lines at a dose of 2 Gy and 
Philenoptera violacea (klotzsch) Schrire showed less 
potential to scavenge free radicals [12], thus it was 
excluded in the determination of radioprotective 
effect. Therefore, the present study aimed at (1) 
investigating the mutagenicity, antimutagenicity, (2) 
investigating the cytotoxicity effects, (3) 
determination of the chemical composition of both 
plants extracts, and (4) evaluating radioprotective 
activity of Xanthocercis zambesiaca (Baker) Dumaz-
le-Grand. 
Methods 
Plant material 
The plant materials Philenoptera violacea (klotzsch) 
Schrire and Xanthocercis zambesiaca (Baker) Dumaz-
le-Grand were authenticated by scientists at the 
National Botanical Gardens in Bloemfontein South 
Africa (MAS002). The collected materials were dried 
at room temperature and pulverized by mechanical 
mills and weighed. It was then stored in a cool place 
until analysis. 
 
Extraction method 
The extraction was done using soaking method. Plant 
material (10g of the dried twig, leaves and flowers of 
each plant) was weighed, pulverized and soaked with 
methanol for 72 hours with occasional stirring.  The 
extracts were filtered and new solvent was added 
again for more extraction until the solvent remains 
clear. The methanol solvent was removed completely 
by rotator evaporator. 
 
Sterilization 
Autoclavable materials such as agar and broth were 
aseptically sterilized in an autoclave at 121ºC for 15 
minutes. Petri dishes, beakers, McCartney bottles, 
pipette, test tubes, filter papers and other metal 
apparatus such as spatula and forceps were sterilized 
using hot air oven at a temperature of 160ºC for 1 
hour. The wire loops were sterilized by heating on 
the blue flame of the Bunsen burner until red-hot 
and allowed to cool and 70% alcohol was used to 
swab/clean the work bench area to prevent 
contamination. The process was carried out 
aseptically. 
 
Preparation of culture media and organisms 
All culture media were prepared according to 
manufacturers’ instructions, agar was dissolved by 
boiling with the microwave and autoclaved at 121ºC 
for 15 minutes. The bacterial strains used for 
mutagenicity testing are the histidine-requiring 
Salmonella typhimurium tester strains TA98 (detects 
frameshift mutagens) and TA100 (detects mutagens 
that cause base-pair substitution) without metabolic 
activation.  
 
Mutagenic and antimutagenic screening 
The sample residues were dissolved in DMSO to a 
known concentration (5000, 500 and 50 g/ml) prior 
to biological activity testing. The potential mutagenic 
effects of the investigated extracts were detected 
using the Ames test. The Ames assay was performed 
with Salmonella typhimurium strains TA98 and 
TA100 using the plate incorporation procedure 
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described by Maron and Ames [13]. Briefly, One 
hundred microliters of bacterial stock was 
incubated in 20 ml of Oxoid Nutrient for 16 h at 
37ºC on an orbital shaker. The overnight culture 
(0.1 ml) was added to 2ml top agar (containing 
traces of biotin and histidine) together with 0.1 ml 
test solution (test extract, solvent control or 
positive control) and 0.5 ml phosphate buffer (for 
exposure without metabolic activation). The top 
agar mixture was poured over the surface of the 
agar plate and incubated for 48 h at 37ºC. After 
incubation, the number of revertant colonies 
(mutants) was counted. All cultures were made in 
triplicate (except the solvent control where up to 
five replicates were made) for each assay. The 
positive control used was 4-nitroquinoline-1-oxide 
(4-NQO) at a concentration of 2 µg/ml. Results were 
expressed as mean ± standard deviation and are 
based on number of induced revertant colonies. 
 
Cytotoxicity screening 
The cytotoxicity screening was analysed using SRB 
assay which was performed at CSIR; Pretoria, South 
Africa in accordance with the protocol of the Drug 
Evaluation Branch, NCI, and the assay has been 
adopted for this screen. The WI-38 cell line - normal 
Human Fetal Lung Fibroblast from European 
Collection of Cell Cultures (ECACC) was routinely 
maintained as a monolayer cell culture at 37ºC, 5% 
CO2, 95% air and 100% relative humidity in Eagle's 
minimal essential medium (EMEM) containing 10% 
fetal bovine serum, 2 mM L-glutamine and 50µg/ml 
gentamicin.  For screening experiment, the cells 
were inoculated in a 96-well microtiter plates at 
plating densities of 10 000 cells/well and were 
incubated for 24 h. After 24 h the cells were treated 
with the experimental drugs which were previously 
dissolved in DMSO and diluted in medium to 
produce 5 concentrations. The plates were 
incubated for 48 h after addition of the compounds. 
Viable cells were fixed to the bottom of each well 
with cold 50% trichloroacetic acid, washed, dried 
and dyed by SRB. Unbound dye was removed and 
protein-bound dye was extracted with 10mM Tris 
base for optical density determination at the 
wavelength 540 nm using a multiwell 
spectrophotometer. The IC50 was then calculated. 
Data analysis was performed using GraphPad Prism 
software 50% of cell growth inhibition (IC50) and 
was determined by non-linear regression. Cells 
without drug addition served as control, the blank 
contained complete medium without cells and 
Etoposide was used as a standard. 
  
Identification of active compounds with LC-MS 
LC–MS/MS analysis for the identification of active 
compounds from Philenoptera violacea (klotzsch) 
Schrire and Xanthocercis zambesiaca (Baker) Dumaz-
le-Grand methanol crude extracts was carried out 
using the Waters Synapt G2 instrument. This is an 
Agilent 1100 LC system consisting of degasser, binary 
pump, auto sampler and column heater. The column 
outlet was coupled to an Agilent MSD Ion Trap XCT 
mass spectrometer equipped with an ESI ion source. 
Data acquisition and mass spectrometric evaluation 
were carried out on a personal computer with 
Acquity binary solvent manager instrument system. 
For the chromatographic separation, Waters UPLC on 
a Waters BEH C18, 2.1x100 mm column was used. 
The column was held at 95% solvent A (0.1% formic 
acid in water) and 5% solvent B (0.1% formic acid in 
acetonitrile) for 1 min, followed by an 11 min step 
gradient from 5% B to 100% B, then it was kept for 4 
min with 100% B; finally, the elution was achieved 
with a linear gradient from 100% B to 5% B for 2 min. 
The flow rate was 0.4 ml/min and the injection 
volume was 0.01 ml. The following parameters were 
used throughout all MS experiments: for 
electrospray ionization with negative ion polarity the 
capillary voltage was set to 3 kV, the drying 
temperature to 3500C and cone voltage of 15 V, the 
maximum nebulizer pressure to 15000 psi and the 
seal wash was 5 min. The total run time was 15 
minutes, the scan speed was 26 000 m/z/s (ultra-
scan mode) and the lock mass was Leucine 
enkaphelin. The phenolics were identified using a 
combination of HPLC with diode array detection and 
liquid chromatography with atmospheric pressure 
chemical ionization mass spectrometry (ESI-
LC/MS/MS) on the basis of their ultraviolet  spectra, 
mass spectra and by comparison of the spectra with 
those of available authentic standards. 
 
Clonogenic assay for Radioprotective effect 
Human prostate cancer cells (DU145) were obtained 
from Professor P Bouic (Synexa Life Sciences, 
Montague Gardens, South Africa), and grown in 
Minimum Essential Medium (Sigma-Aldrich, 
Germany) supplemented with 10% heat-inactivated 
fetal bovine serum (HyClone, UK), penicillin (100 
U/ml) and streptomycin (100 µg/ml) (Lonza, 
Belgium). Cultures in exponential growth were 
trypsinised to give single-cell suspensions, plated in 
triplicate (400–1500 cells per flask) into 25 cm2 tissue 
culture flasks (Greiner Bio-One, Frickenhausen, 
Germany) and incubated for 3 hours to allow the 
cells to attach. To confirm the free radical scavenging 
features of extract Xanthocercis zambesiaca (Baker) 
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Dumaz-le-Grand, cell cultures were irradiated to 2 
Gy in the presence of the extract at a concentration 
of 0.1 mg/ml, and were subsequently incubated at 
37°C in a humidified atmosphere (95% air and 5% 
CO2) for 10 days to allow for colony formation. The 
cells were irradiated using a 60Co -irradiation 
source at a dose rate of 0.827 Gy/min. Colonies 
were fixed in glacial acetic acid:methanol:water 
(1:1:8, by volume), stained with 0.01% amido black 
in fixative, counted, and the cell surviving fraction 
[SF2 (with Xanthocercis zambesiaca (Baker) Dumaz-
le-Grand extract)] was determined. Another batch 
of cell cultures was irradiated to 2 Gy in the 
absence of extract and the corresponding surviving 
fraction [SF2 (no Xanthocercis zambesiaca extract)] 
was obtained. To evaluate the radioprotective 
capacity of the extract, an RPF was derived as:   
 
RPF = SF2 (with Xanthocercis zambesiaca)  
               SF2 (without Xanthocercis zambesiaca) 
 
Statistical analysis 
All analyses were run in triplicate and the results 
expressed as mean ± standard deviation (SD). Fifty 
percent of cell growth inhibition (IC50) was 
determined by non-linear regression. Data analysis 
was performed using Graph Pad Prism software. 
  
Results 
Mutagenic and anti-mutagenic screening results 
(Table1) 
 
Cytotoxicity screening results 
(Figure 1) 
 
Identification of active compounds with LC-MS 
(Figure 2, Figure 3, Table 2, Table 3) 
 
Radioprotective effect results 
Based on the clonogenic assay, the cell surviving 
fractions for DU145 at 2 Gy with and without 
Xanthocercis zambesiaca (Baker) Dumaz-le-Grand 
were found to be 0.23 ± 0.13 and 0.15 ± 0.10, 
respectively. The corresponding RPF value emerged 
as 1.53 ± 0.57, indicating that an extract of 
Xanthocercis zambesiaca (Baker) Dumaz-le-Grand 
can lead to over 50% reduction in cell death.  This 
confirms the free radical scavenging features of the 
extract and suggests that it might be useful as a 
radioprotector. 
  
Discussion 
Mutagenicity and antimutagenicity activity 
People have been relying on traditional medicine 
since ancient times but as some natural plants are 
toxic and can be carcinogenic through a process of 
mutation, there is a need to determine the safety of 
these traditional medicines. Traditional medicine can 
be described as unsafe until proven to be safe. 
People can use traditional medicine for years without 
knowing the toxicity or damage the medicine is doing 
to them. Compounds from secondary plant 
metabolism can be beneficial to human beings, but, 
some are toxic and makes mutagenicity effect [17] 
when used by human population. Gómez-Arroyo et 
al., demonstrated a high correlation between 
mutagenicity and carcinogenicity [18]. The Ames 
mutagenicity test is a short term bacterial reverse 
mutation assay specifically designed to detect a wide 
range of chemical materials that can produce genetic 
damage that leads to gene mutations [19]. The Ames 
test can play a central role in a program of 
prevention to identify mutagenic chemicals and to 
aid in the development of non-mutagenic products 
to prevent future human exposure [20]. 
The Ames assay is commonly used to detect 
mutagenic and antimutagenic activities and is a 
widely accepted method for identifying different 
chemicals and drugs that can cause bacterial reverse 
mutations. These gene mutations act as hot spots for 
mutagens that cause DNA damage via different 
mechanisms. When the Salmonella tester strains are 
grown on a minimal media agar plate containing a 
trace of histidine, only those bacteria that revert to 
histidine independence are able to form colonies 
[21]. In this study, we investigated the mutagenic 
and antimutagenic activities of Philenoptera violacea 
(klotzsch) Schrire and Xanthocercis zambesiaca 
(Baker) Dumaz-le-Grand by the S. 
typhimurium/microsome assay, without addition of 
an extrinsic metabolic activation system [22].  
The Ames test is a well-known bacterial mutagenicity 
test [21, 23]. In this test, reverse His− →His+ 
mutations is visualised by plating Salmonella 
typhimurium bacteria in a histidine-poor growth 
mutants that are able to form medium. In this 
medium only, His+ will able to form visible colonies. 
Different bacterial strains are used to identify 
different types of mutations. In this study, bacterial 
strains used for mutagenicity testing are the 
histidine-requiring Salmonella typhimurium tester 
strains TA98 and TA100 without metabolic activation. 
Strain TA98 gives an indication of frame-shift 
mutations, while strain TA100 indicates base-pair 
substitution. The colonies were counted to 
determine the mutagenic and antimutagenic activity 
of these two plant extracts. For a substance to be 
considered mutagenic in the Ames test, the number 
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of revertant colonies on the plates containing the 
test compounds should be more than twice the 
number of colonies produced on the solvent control 
plates. In addition, a dose-response should be 
evident for the various concentrations of the 
mutagen tested. Results obtained from the 
mutagenicity test of Philenoptera violacea (klotzsch) 
Schrire and Xanthocercis zambesiaca (Baker) 
Dumaz-le-Grand plant are expressed as mean ± 
S.E.M (Table 1) and are based on number of 
induced revertant colonies. 
Substances are considered active or mutagenic if 
the number of induced revertant colonies is twice 
the revertant colonies of the negative control [13]. 
From our results (Table 1), the numbers of 
revertant colonies on the plates containing the test 
compounds were not more than twice the number 
of colonies produced on the solvent control plates. 
Thus, neither Philenoptera violacea (klotzsch) 
Schrire, nor Xanthocercis zambesiaca (Baker) 
Dumaz-le-Grand were mutagenic in the Salmonella 
tester strain TA 100 and TA98. Both plants extracts 
showed positive antimutagenic activity as they 
repressed the growth of strain TA98 which gives an 
indication of frame-shift mutations and of strain 
TA100 which indicates base-pair substitution. 
Phenolics are used as antimutagenic and anti-
inflammatory agents due to their strong antioxidant 
properties [24]. Based on research findings by 
Ntsoelinyane et al., the antimutagenicity activity of 
Philenoptera violacea (klotzsch) Schrire and 
Xanthocercis zambesiaca (Baker) Dumaz-le-Grand 
extracts can be due to the presence of phenolic 
compounds in these plant extracts [12].  
  
Cytotoxicity activity 
The SRB assay is used to measure drug-induced 
cytotoxicity and cell proliferation. Its principle is 
based on the ability of the protein dye 
sulforhodamine B (Acid Red 52) to bind 
electrostatically in a pH-dependent manner to 
protein basic amino acid residues of trichloroacetic 
acid-fixed cells. Under mild acidic conditions it binds 
to the fixed cellular protein, while under mild basic 
conditions it can be extracted from cells and 
solubilized for measurement. The results of five 
dose screening were reported as 50% of cell growth 
inhibition (IC50). The biological activities were 
separated into 4 categories: Low Hazard (IC50 >100 
μg/ml), weak Hazard (30 μg/ml < IC50 <100 μg/ml), 
moderate Hazard (5 μg/ml < IC50 <30 μg/ml) and 
High Hazard (IC50 <5 μg/ml). According to criterion 
CSIR cytotoxicity criteria, Philenoptera violacea 
(klotzsch) Schrire and Xanthocercis zambesiaca 
(Baker) Dumaz-le-Grand plant extracts can be 
considered as Low Hazard as the parameter IC50 for 
WI-38 cell line was higher than 100 μg/ml. While 
Etoposite can be considered as High Hazard as the 
parameter IC50 for WI-38 cell line was less than 5 
μg/ml. From these results (Figure 1), we can 
conclude that Philenoptera violacea (klotzsch) Schrire 
and Xanthocercis zambesiaca (Baker) Dumaz-le-
Grand plant extracts do not have cytotoxic activity on 
normal cells.  
  
Identification of compounds 
There are two classes of compounds from plants, 
namely primary and secondary metabolites. Primary 
metabolites are required for the sustenance of the 
plant, while secondary metabolites are not a 
necessity for the plant’s survival [25]. The latter are 
mostly compounds that are active for treatment and 
prevention of diseases in humans and animals and 
are thus termed bioactive compounds. Bioactive 
compounds are generally unique to individual plant 
species and are thus species-specific, but some may 
be found in several or many plant species of a genus, 
in several related genera, or even families [26]. The 
crucial factor for definitive accomplishment of 
isolating bioactive plant constituents is the selection 
of the “right” plant and the relevant part of the 
plant, which contains the active compounds. As 
distillate, certain secondary metabolites in specific 
organs and variation in bioactivity are often 
encountered in different parts of the same plant 
[27]. In this study, LCMS techniques have been 
employed to investigate the phenolic content of 
Philenoptera violacea (klotzsch) Schrire and 
Xanthocercis zambesiaca (Baker) Dumaz-le-Grand 
methanol plant extracts. This was aimed at 
identifying only compounds present in these plant 
extracts, but not to isolate and re-analyze the activity 
of the isolated active compounds. Fragmentation of 
the compounds by the mass spectrum was 
performed to obtain the molecular chemical formula 
of the compounds that formed significant peaks. The 
relative retention times and mass spectra of the 
extract components were compared with those of 
authentic samples and with mass spectra from a data 
library. As shown in Figure 2, LC-MS analysis of the 
Philenoptera violacea (klotzsch) Schrire methanol 
extract resulted in the identification of nine 
compounds, with more than 90% similarity with the 
standard mass spectra in the library. The LC-MS 
analysis of Xanthocercis zambesiaca (Baker) Dumaz-
le-Grand extract shown in Figure 3 resulted in the 
identification of seven compounds, also with more 
than 90% similarity with the standard mass spectra in 
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the library. In short, for Philenoptera violacea 
(klotzsch) Schrire LC-MS analysis, the first five 
components with the greatest peak area to be 
eluted were at 2.24 min till 3.32 min (peak 1 to 
peak 5), which was in the more hydrophilic region 
(short retention time). The other four main 
components eluted at 6.47 min (peak 6), 7.81 min 
(peak 7), 6.87 min (peak 8) and 8.04 min (peak 9) in 
the more hydrophobic region (longer retention 
time). Then, for Xanthocercis zambesiaca (Baker) 
Dumaz-le-Grand LC-MS analysis, the first three 
components were eluted in the more hydrophilic 
region, with the greatest peak area at 2.75 min till 
3.69 (peak 1 to peak 3) and the other four main 
components eluted in the more hydrophobic region 
at 4.93 min till 6.84 min (peak 4 to peak 7). The 
deprotonated molecule mass (m/z) measured by 
the MS in ESI negative mode was used to determine 
the molecular formula of the compounds extracted. 
The tentative names of these identified compounds 
were determined using the molecular formula and 
the molecule mass, using the literature [15]. 
Previous investigations of Xanthocercis zambesiaca 
(Baker) Dumaz-le-Grand revealed the presence of 
7,8-dioxy-isoflavonoids, 2-benzylbenzo[b]furan-
3(2H)-ones [28], along with the isolation of novel 
isoflavones, 7,8,3’-trihydroxy-4’-methoxyisoflavone 
and α,3,4,4’-tetrahydroxy-2’-
methoxydihydrochalone [29]. However, these were 
isolated from the heartwood of the plant and it is 
known that different parts of the plant may contain 
dissimilar compounds. Xanthocercis zambesiaca leaf 
extract was demonstrated to have five compounds, 
namely fagomine, 3-epi-fagomine, 3,4-di-epi-
fagomine, 3-O-β-d-glucopyranosylfagomine and 4-
O-β-d-glucopyranosylfagomine [30]. The two 
compounds mentioned last were identified as new 
natural products. Fagomine is a good inhibitor of 
isomaltase and certain α- and β-galactosidases, 
whereas 3-epi-fagomine is a more potent inhibitor 
of isomaltase and β-galactosidases than fagomine, 
but does not inhibit α-galactosidase. Compound 
3,4-di-epi-fagomine exhibited no significant 
inhibition against the glycosidases used [30]. 
Xanthocercis zambesiaca was also identified as 
having diarylpropanes such as diarylalkanes and/or 
diarylalkanols, which have the capability of 
inhibiting binuclear enzyme function, particularly 
tyrosinase, which prevents melanin overproduction. 
When one considers that a single plant may contain 
up to thousands of phytoconstituents, the 
possibilities of making new discoveries become self-
evident. Our phytochemical investigation of 
Xanthocercis zambesiaca (Baker) Dumaz-le-Grand 
and Philenoptera violacea (klotzsch) Schrire (mixture 
of leaves, twigs and flowers) has resulted in the 
identification of other compounds of which the 
presence has not been recorded before from these 
specific parts of the plants. 
The following compounds were identified from this 
study (Table 3): 4-Acetoxy-3,5-dimethoxybenzoic 
acid, 2″-O- β –D-Apriofuranosyl, 6″-O-α-L-
rhamnopyranosyl, Quercetin-3-O-[α-L- 
rhamnopyranosyl(1→6)]-β –D-galactofuranoside, 3-
O- β –D-Galactopyranosyloxy-3’ .4’ .5.7-
tetrahydroxyflavone. Quercetin 3-galactoside, 7-O-
[α-L-Rhamnopyranosyl-(1→6)- β-D-glucopyranoside] 
or 6,8-Bis(C-β-glucosyl)-apigenin, 3-O-[α-L-
Rhamnopyranosyl-(1→2)-β-D-glucopyranoside], 20-
O-α-L-rhamnopyranoside and 2 unknown compounds  
from Philenoptera violacea (klotzsch) Schrire, and 7 
compounds: Apigenun-6-C-α-L-arabinopyranosyl-8-C- 
β –L-arabinopyranoside, Metaplexigenin-3-O- β-D-
oleandropyranosyl-(1→4)- β-D-digitoxopyranosyl –
(1→4)- β-D-digitoxopyranoside, Arvenin I, 3-O- β-D-
Glucuronopyranoside: (Cloversaponin II), Apigenin-4’-
O- β –D-xylofuranodyl(-(1→4)-O- β-D-
glucopyranoside and 6-Me ether, 7-O- β –D-
galactopyranoside: (Chamaejasmoside) from 
Xanthocercis zambesiaca (Baker) Dumaz-le-Grand. 
There was no literature on the identification of these 
compounds from species belonging to the Fabacea 
family. Therefore, this is the first report of the 
presence of these compounds from methanol extract 
(leaf, twig and flower mixture) from Philenoptera 
violacea (klotzsch) Schrire and Xanthocercis 
zambesiaca (Baker) Dumaz-le-Grand belonging to the 
Fabacea family. Xanthocercis zambesiaca (Baker) 
Dumaz-le-Grand was found to contain compounds 
with a molecule structure named ‘pyranoside’ and 
‘pyranosyl’ in abundance. Pyranoside has been 
reported to possess neuroprotective properties [31-
32] and pyranosyl has been reported as an iron-
chelating agent. Furthermore, control of iron in the 
body by chelating drugs may have a significant 
beneficial effect on tissue damage caused by free 
radicals [33]. Therefore, the presence of this 
molecule in Xanthocercis zambesiaca (Baker) Dumaz-
le-Grand may support its activity against free 
radicals, as demonstrated by Ntsoelinyane et al., 
[12]. Philenoptera violacea (klotzsch) Schrire has also 
been found to contain pyranoside pyranosyl and two 
unknown compounds. These compounds where 
identified as 4-Acetoxy-3,5-dimethoxybenzoic acid, 
2″-O- β –D-Apriofuranosyl, 6″-O-α-L-
rhamnopyranosyl, Quercetin-3-O-[α-L- 
rhamnopyranosyl(1→6)]-β -D-galactofuranoside, 3-
O- β –D-Galactopyranosyloxy-3' .4' .5.7- 
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tetrahydroxyflavone, Quercetin 3-galactoside, 7-O-
[α-L-Rhamnopyranosyl-(1→6)- β-D-
glucopyranoside] or 6,8-Bis(C-β-glucosyl)-apigenin, 
3-O-[α-L-Rhamnopyranosyl-(1→2)-β-D-
glucopyranoside], 20-O-α-L-rhamnopyranoside and 
two unknown compounds.  In addition to that, 
flavonoids were present in abundance. Flavonoids 
are classified into various classes [34], such as 
flavonols (quercetin), flavones (apigenin), 
flavanones (hesperetin, naringenin), flavonoid 
glycosides (astragalin, rutin), flavonolignans 
(silibinin), flavans (catechin, epicatechin) to name a 
few. Flavones are reported as possible antioxidant, 
anti-proliferative, anti-tumor, anti-microbial, 
estrogenic, acetyl cholinesterase, anti-inflammatory 
agents and are also used to treat cancer, 
cardiovascular disease and neurodegenerative 
disorders [35-36]. Despite the presence of 
abundant flavones in this plant extract, tests for its 
anticancer, antioxidant and antimicrobial activity 
yielded negative results. Therefore there was no 
correlation with the identified active compounds 
and pharmacological activities of this plant and this 
was not expected. This might be due to the 
concentration of these compounds; they are 
present, but not in large quantities. To elucidate 
this, each part of this plant must be analyzed 
separately and a quantitative analysis to determine 
the amount of active flavonoids present must be 
done in the future. 
  
Radioprotective effect 
Traditionally, radioprotectors are defined as agents 
that are administered before radiation exposure, 
whereas therapeutic agents are administered after 
exposure. Many naturally occurring antioxidants 
exhibit a long window of protection, including post-
irradiation protection against lethality and 
mutagenesis [37]. To prove the radioprotective 
capacity of antioxidants present in Xanthocercis 
zambesiaca (Baker) Dumaz-le-Grand plant extracts, 
we applied the extract to radiated cancer cells. 
Xanthocercis zambesiaca (Baker) Dumaz-le-Grand 
plant extract studied in this project showed the 
capability of offering 50% protective effect but was 
less toxic than synthetic radioprotectors, such as 
phosphorothioates. The potential application of this 
plant as a protective agent shows promise - either 
prophylactic benefits for anticipated exposure in 
emergency situations or therapeutic benefits after 
radiation accidents/incidents. We have previously 
reported the free radical scavenging activity of 
Xanthocercis zambesiaca (Baker) Dumaz-le-Grand 
[12]. In continuation, the present in vitro studies 
were undertaken to elucidate its precise role in the 
modulation of radiation-induced damage in human 
prostate cancer cell line. DU145 cells were treated 
with radiation using a 60Co -irradiation source at a 
dose rate of 0.827 Gy/min in order to determine 
radiation-induced damage. Radiation-induced DNA 
clustered lesions and apoptosis are the major likely 
mechanisms implicated in clonogenic cell death. 
Radiation exposure (2 Gy) triggered a loss of 
clonogenicity in DU145 cells. Cell growth is hindered 
by alteration of membrane permeability, damage to 
DNA and proteins responsible for cell cycle 
progression [38]. Cell count studies and cell surviving 
fraction values were determined, and the RPF value 
obtained indicated that Xanthocercis zambesiaca 
(Baker) Dumaz-le-Grand plant extract can lead to 
over 50% reduction in cell death. Nuclear and 
radiological accidents can result in moderate to 
severe radiation injuries and many casualties. The 
harmful impact of -radiation on biological systems is 
well researched and documented. Aglycones, which 
are compounds remaining after the glycosyl group on 
a glycoside is replaced by a hydrogen atom, were 
proven to have high radioprotective capacity. The 
observed radioprotective effect of this compound 
was explained by Konopacka et al., to result from its 
antioxidant properties [39]. From identified 
compounds, aglycones were found in abundance in 
Xanthocercis zambesiaca (Baker) Dumaz-le-Grand, 
therefore its radioprotective activity compared 
relatively well to aglycones’ radioprotective capacity. 
The results obtained suggested that the free radical 
scavenging activity agents present in this plant 
extract may be used as compounds with promising 
radioprotective potential. However, these results 
could be influenced by the increase in cell number 
and competition among growing cells for the 
available, but limited supply of nutrients and growth 
factors. Such argumentation in cell growth or 
proliferation rate against radiation damage could be 
the result of several factors, such as inhibition of free 
radical generation, repair of damaged DNA, 
protection of cell membrane and an increase in the 
producing ability of cells. Furthermore, the 
predominant mechanism of radiation injury, both in 
tumors and in normal tissues, is by induction of 
apoptosis or clonogenic cell death by free radical-
mediated DNA damage [40]. Thus, screening potent 
free radical scavengers as radioprotectors is one of 
the important strategies of drug development. 
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Test Sample TA98 TA100 
Number of colonies (revertants) Number of colonies (revertants) 
Concentration (g/ml) Concentration (g/ml) 
5000 500 50 5000 500 50 
Philenoptera 
violacea 
(klotzsch) 
Schrire 
34.34.9 43.53.5 33.74.0 211.721.6 143.733.8 152.010.4 
Xanthocercis 
zambesiaca 
(Baker) Dumaz-
le- Grand 
36.34.0 36.76.8 40.02.6 158.38.1 159.712.5 160.31.5 
4NQO (1) 157.3.22.0 355.020.8 
Solvent control 26.62.7 155.68.3 
Table 1: No. of his+ revertants in Salmonella typhimurium strains TA98 and TA100 produced by Philenoptera 
violacea (klotzsch) Schrire and Xanthocercis zambesiaca (Baker) Dumaz-le-Grand plant extract. 
Figure 1: IC50 of methanol extract of Philenoptera violacea (klotzsch) Schrire (<100 μg/ml) and Xanthocercis 
zambesiaca (Baker) Dumaz-le-Grand (<100 μg/ml) on WI-38 cell line against Etoposite (4.1 µg/ml). 
Figure 2: LC/MS chromatograms of Philenoptera violacea (klotzsch) Schrire extract (ESI negative). Nine phenolic 
components were identified. 
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Figure 3: LC/MS chromatograms of Xanthorcercis zambesiaca (ESI negative). Seven phenolic components were 
identified. 
Peak (m/z) Rt 
(min) 
Tentative ID References 
1 239.05 2.24 4-Acetoxy-3,5-dimethoxybenzoic 
acid  
[14] 
2 741.18 2.71 2″-O- β –D-Apriofuranosyl, 6″-O-α-
L-rhamnopyranosyl 
[15] 
3 609.14 2.94 Quercetin-3-O-[α-L- 
rhamnopyranosyl(1→6)]-β -D-
galactofuranoside 
[16] 
4 463.08 3.09 3-O- β –D-Galactopyranosyloxy-3' 
.4' .5.7-tetrahydroxyflavone. 
Quercetin 3-galactoside 
[15] 
5 593.14 3.32 7-O-[α-L-Rhamnopyranosyl-(1→6)- 
β-D-glucopyranoside] 
or 6,8-Bis(C-β-glucosyl)-apigenin 
[16] 
6 925.51 6.47 3-O-[α-L-Rhamnopyranosyl-(1→2)-
β-D-glucopyranoside], 20-O-α-L-
rhamnopyranoside 
[16] 
7 895.50 6.87 Unknown * 
8 721.36 7.81 2-oxepanone; 2-propenoic acid [3-
hydroxy-2-[[3-hydroxy-2,2 
bis(hydroxymethyl)propoxy]methyl
]-2-hydroxymethyl)propyl] ester; 2-
propenoic acid 1-[2-[2-(1-oxoprop-
2 enoxy)propoxy]propoxy]propan-
2-yl ester 
[15] 
9 293.21 8.04 Unknown * 
Table 2: Identification of 
phenolic compounds of 
Philenoptera violacea (klotzsch) 
Schrire methanol extracts using 
their mass unit and retention 
times. Identification was aided 
by comparison with previous 
literature reports. (m/z) = 
Molecular mass, Rt = retention 
time, * = no literature 
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Peak (m/z) Rt (min) Tentative ID References 
1 563.14 2.75 Apigenin-4’-O- β –D-xylofuranodyl(-
(1→4)-O- β-D-glucopyranoside and 6-
Me ether 
[16] 
2 533.1 2.29 Apigenun-6-C-α-L-arabinopyranosyl-8-
C- β -L-arabinopyranoside,  
[16] 
3 513.1 3.69 7-O- β –D-galactopyranoside: 
(Chamaejasmoside) 
[15] 
4 825.4 4.93 Metaplexigenin-3-O- β-D-
oleandropyranosyl-(1→4)- β-D-
digitoxopyranosyl -(1→4)- β-D-
digitoxopyranoside 
[15] 
5 719.3 5.80 23,24-Dihydro, 25-Ac, 2-O-b-D-
glucopyranoside: 
[15] 
6 749.37 6.54 5E,8Z,11Z,14Z)-eicosa-5,8,11,14-
tetraenoic acid [1-acetyloxy-3-
[[(3R,4R,5S)-3,4,5-triacetyloxy-6-
(acetyloxymethyl)-2-
oxanyl]oxy]propan-2-yl] ester 
[14] 
7 661.35 6.84 3-O- β-D-Glucuronopyranoside: 
(Cloversaponin II) 
[15] 
Table 3: Identification of phenolic compounds in Xanthocercis zambesiaca (Baker) Dumaz-le-Grand 
methanol extract using their mass unit and retention times. Identification was aided by comparison 
with previous literature reports. (m/z) = Molecular mass, Rt = retention time 
